• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Stanford Aging and Ethnogeriatrics Research Center (SAGE Center)

Stanford Aging and Ethnogeriatrics Research Center (SAGE Center)

Ace Aging

  • LinkedIn
  • Twitter
  • Home
  • About Us
  • Awardees
  • Faculty
  • Research Methodology Podcasts
  • Research
  • Contact Us

SAGE awardees

Gen Shinozaki, MD

Associate Professor
Department of Psychiatry and Behavioral Sciences

https://profiles.stanford.edu/gen-shinozaki

Dr. Gen Shinozaki earned his MD degree from the University of Yamanashi, Japan. He has a Master’s degree in quantum optics from the University of Tokyo and in bioinformatics from the University of Iowa. He completed his psychiatry residency and consultation-liaison psychiatry fellowship both at Mayo Clinic, Rochester, MN. Prior to joining Stanford, he was a faculty at the University of Iowa where he received K23 as well as R01 awards from NIH.

Dr. Gen Shinozaki’s research interests include investigation epigenetics mechanism of delirium pathophysiology, neuroinflammation and aging using human and mouse samples. Dr. Shinozaki’s group aims to develop epigenetic biomarkers for delirium to predict, detect and monitor illness course, treatment response and patient outcomes. They are also working on a small point-of-care EEG device to detect delirium and predict patient outcome.

SAGE Project: Epigenetic investigation of delirium

Delirium among older adult patients, especially with Alzheimer’s disease (AD) and other dementia, is associated with long-term cognitive decline (LTCD) and high mortality.
It is dangerous and common after surgery, yet it is underdiagnosed and undertreated. Delirium also exposes older adult patients to a greater risk of developing AD, and AD patients are more likely to develop delirium. Given this connection and potential cause for disease, it is critically important to predict which patients are at risk for delirium and to develop cognitive decline and to lead to ADRD. The goal of this project is to identify epigenetic markers that are predictive of postoperative delirium (POD) in whole blood and monocytes obtained from patients prior to surgery in order to better understand the basis of this condition so that it can be detected earlier and treated promptly.

Share this:

  • Twitter
  • Facebook
Previous Post: « Shoa Clarke, MD, PhD
Next Post: Ngan F. Huang, PhD  »

Ace Aging

Footer

Stanford Medicine

  • About
  • School Administration
  • Contact
  • Maps & Directions
  • Jobs

 

  • Basic Science Departments
  • Clinical Science Departments
  • Academic Programs
  • Diversity Programs

Healthcare

  • Find a physician
  • Clinical Trials
  • Patient Information
  • Contact

Related

  • Ethnogeriatrics
  • Salud (Spanish Health Site)
  • Project Respect
  •   Find People
  •   Visit Stanford
  •   Search Clinical Trials
  •   Give a Gift

Copyright © 2023 Stanford Medicine
Privacy Policy | Terms of Use

    Next-Generation Artificial Intelligence for Diagnosis: From Predicting Diagnostic Labels to "Wayfinding"

    Julia Adler-Milstein, PhD1; Jonathan H. Chen, MD, PhD; Gurpreet Dhaliwal, MD

    Improving the diagnostic process is a quality and safety priority.With the digitization of health records and rapid expansion of health data, the cognitive demand on the diagnostician has increased. The use of artificial intelligence (AI) to assist human cognition has the potential to reduce this demand and associated diagnostic errors. However, current AI tools have not realized this potential, due in part to the long-standing focus of these tools on predicting final diagnostic labels instead of helping clinicians navigate the dynamic refinement process of diagnosis. This Viewpoint highlights the importance of shifting the role of diagnostic AI from predicting labels to “wayfinding” (interpreting context and providing cues that guide the diagnostician).